Register or sign in:

IMGN - ImmunoGen Inc

Will $IMGN overperform S&P500 ?

Press the button to answer!

Statistics

total days in fund: 0 / 8115
liquidity: 1,107,333
current price: $13.61 05.04.2012
price change: -1.31% since 04.04.2012

current rating: 96.74 05.04.2012
highest rating: 336.05 03.07.2002
lowest rating: 12.62 01.04.2010

Chart is loading...


Company info

ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States.

Best company experts on $IMGN

Scores are based on forecasts for last three years.
There are no experts for $IMGN at the moment.
Vote for $IMGN and become the first expert!

Active forecasts for $IMGN

There is no active forecasts for $IMGN. You can make a forecast, using the form on the left.


Closed forecasts for $IMGN

  • brokerrbc-capital-mkts (rating: 24.15)
    30. March 2012 - 6. April 2012
     -4.68% details »
  • brokerrbc-capital-mkts (rating: 24.15)
    23. March 2012 - 30. March 2012
     +2.71% details »
  • brokerrbc-capital-mkts (rating: 24.15)
    16. March 2012 - 23. March 2012
     +2.48% details »
  • brokerrbc-capital-mkts (rating: 24.15)
    9. March 2012 - 16. March 2012
     +0.59% details »